Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
ABSTRACT: Polycystic ovary syndrome (PCOS) is a multifactorial disorder traditionally recognized for its endocrine and metabolic disturbances. However, accumulating evidence indicates that chronic low-grade inflammation and immune dysregulation play a central role in its pathophysiology. This narrative review explores the immunological mechanisms underlying PCOS and their repercussions for reproductive outcomes. Women with PCOS exhibit increased circulating levels of inflammatory...
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Thaís Bastos Romero, Daniel de Sousa Sobral, Lara Andryne Alves Aguiar, Helena Aben-Athar Ponte, Ricardo Espíndola Romero Filho, Ana Luiza Rangel Montenegro, Marla Girão Ramos Maia, Thiago Gonçalves Marques, Laís de Oliveira Martins, Marcelo Borges Cavalcante,
ImportanceOcular manifestations of polycystic ovarian syndrome (PCOS), particularly related to elevated testosterone, are understudied.ObjectiveTo evaluate prevalence and odds of ocular diseases in PCOS patients using large-scale electronic health records (EHRs).DesignCross-sectional study comparing females aged 15-50 with PCOS (n = 494,557) to two controls: total female population (n = 32,162,331) and BMI ≥30 (n = 4,895,226), based on ICD-10 ocular diagnoses. Prevalence odds ratios (PORs) with...
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Ana Lopez, Anna Zhang, David C Kaelber, Katherine E Talcott, Rishi P Singh, Jacqueline Shaia,
CONCLUSION: Findings fill a gap in research using recent population-based US representative data to emphasize the importance of early detection and tailored management strategies for women with PCOS to mitigate the risks of pregnancy complications and support the need for targeted interventions to improve maternal and neonatal outcomes.
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Raegan A Holek, Chelsea Rossow, Sarah Nechuta,
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder characterized by reproductive and metabolic disturbances, which causes a chronic lack of ovulation that leads to increased incidence of atypical endometrial hyperplasia and carcinogenesis. Increasing evidence indicates that metabolic changes may play a crucial role in PCOS pathogenesis; however, the metabolic profile of fluid in PCOS-related endometrium has not yet been characterized. In this study, we successfully constructed...
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Haoxuan Yang, Jing Zhang, Su Long, Yuhuan Xue, Jinfeng Tan, Ge Chen, Yongqi Luo, Ricardo Azziz, Chichiu Wang, Wenming Xu, Xiaomiao Zhao,
Accurate and efficient detection of multiple diseases from diagnostic images remains a major challenge in today's world, especially in women's health conditions such as breast cancer, cervical cancer, and Polycystic Ovary Syndrome (PCOS). Each of these diseases presents its own unique imaging characteristics and visual patterns, making detection of these diseases all together through a single model is highly challenging. In this respect, in order to overcome this, we have proposed a hybrid deep...
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Sonam Juneja, Bhoopesh Singh Bhati, Ghanshyam G Tejani, Seyed Jalaleddin Mousavirad,
CONCLUSIONS: Oral microbiota alterations in PCOS are characterized by consistent Fusobacterium elevation and heterogeneous changes associated with systemic inflammation, metabolic‒endocrine disturbances and poor periodontal health. Despite the limited current evidence, the oral microbiota may serve as a novel entry point for PCOS management. Large, high‑quality prospective studies are warranted to clarify the causal relationship between the oral microbiota and PCOS, and to explore the...
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Qinghua Mao, Chuanxia Liu, Zhimin Yan,
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Menstrual irregularity is a hallmark clinical feature of polycystic ovary syndrome (PCOS), which is an established risk factor for spontaneous abortion. However, robust population-level evidence directly linking specific patterns of menstrual irregularity to spontaneous abortion risk remains lacking, as prior studies have been limited by small sample sizes.
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Tsomo Tenzin, Yumei Wei, Yiyao Jin, Jiaxin Li, Xiaowei Wang, Shenfengxiang Feng, Xinyi Lyu, Yuanyuan Xiong, Hanbin Wu, Jueming Lei, Jihong Xu, Yuan He, Yuanyuan Wang, Ya Zhang, Hongguang Zhang, Ying Yang, Xu Ma,
CONCLUSIONS: PCOS women had comparable depression and FertiQoL scores and lower levels of anxiety and stress when compared to non-PCOS women. Longer duration of infertility and obesity were associated with depression and lower quality of life irrespective of cause.
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Reeta Mahey, Deeksha Patkar, Mani Kalaivani, Chitralok Hemraj, Raman Deep, Aarthi K Jayraj, Robin Badal, Akriti Shukla,
CONCLUSION: Our findings underscore the potential contribution of epigenetic modifications to PCOS pathogenesis, particularly through immune regulation and steroid metabolism. Further studies with larger cohorts and functional validation are warranted to establish the role of these epigenetic changes in PCOS.
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Priyal Sharma, Manish Kumar Tripathi, Vivek Kumar, Manish Jain, Ashutosh Halder,
CONCLUSION: The extended 10-day letrozole regimen significantly improves follicular response without increasing adverse outcomes and may improve cycle efficiency in women with PCOS.
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Bhavneet Kaur, Archana Kumari, Reeta Mahey, Maroof Ahamad Khan, Aarthi K Jayraj, Neena Malhotra,
No abstract
Published on: Thu, 09 Apr 2026 06:00:00 -0400
Authors: Shivam Sharma, Shaheen Wasil Kabeer, Vinod Kumar, Kulbhushan Tikoo,
Polycystic ovary syndrome (PCOS) is a common endocrine disorder with strong heritability, driven by complex metabolic, epigenetic, and gut-microbial dysregulation. While both epigenetic and microbial axes are implicated in PCOS, their integration and contribution to intergenerational transmission remain poorly understood. We investigated whether maternal choline (methyl-donor) and galactooligosaccharide (GOS, prebiotic) supplementation could restore gut-epigenome homeostasis and prevent vertical...
Published on: Thu, 09 Apr 2026 06:00:00 -0400
Authors: Kajal Rawat, Arushi Sandhu, Anil Kumar, Lekha Saha, Alka Bhatia, Pradip Kumar Saha, Rama Walia,
Polycystic ovary syndrome (PCOS) is a common metabolic disorder affecting women of reproductive age. Clinical evidence suggests that the SGLT2 inhibitor canagliflozin has potential therapeutic effects in PCOS; however, its mechanisms remain unclear. The hyperandrogenic state in patients with PCOS leads to disrupted iron metabolism and oxidative stress. Herein, we aimed to investigate whether canagliflozin ameliorates PCOS symptoms by reducing oxidative stress and inhibiting granulosa cell...
Published on: Thu, 09 Apr 2026 06:00:00 -0400
Authors: Jindan Lin, Weilun Cheng, Yilin Liu, Zhiying Zhang, Weiyu Zhou, Yujing Wang, Haiqiao Yu, Yanfei Qi, Shuang Yan,
CONCLUSIONS: This study demonstrates that the BSHT prescription may alleviate reproductive endocrine disorders in PCOS rats by mitigating the inhibitory effects of fat-derived exosomal miR-27a-3p on PPARG.
Published on: Thu, 09 Apr 2026 06:00:00 -0400
Authors: Meng Chen, Ruiyuan Zhang, Ying Huang, Yuxin Pan, Jinrong Yang, Yinghong Huang,
INTRODUCTION: Infertility affects nearly one in six couples worldwide, with approximately half of these cases associated with female-related factors. Among women, ovulatory disorders represent a major cause of infertility, with Polycystic Ovary Syndrome (PCOS) being one of the most prevalent conditions. Traditional diagnostic methods, including ultrasound imaging, hormone analysis, and menstrual history evaluation, often fail to fully utilize comprehensive patient health records. These records...
Published on: Thu, 09 Apr 2026 06:00:00 -0400
Authors: T Sarath, K Brindha,